S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

MDGL Madrigal Pharmaceuticals Inc

335.74

0.00 (0.00%)

Pre Market

Last Updated: 06:02:54

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals Inc News

Form 144 - Report of proposed sale of securities
Thursday 27 February 2025 (15 hours ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 27 February 2025 (15 hours ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 26 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (2 days ago) • Edgar (US Regulatory)

Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
Wednesday 26 February 2025 (2 days ago) • GlobeNewswire Inc.

Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
Wednesday 26 February 2025 (2 days ago) • GlobeNewswire Inc.

Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
Friday 21 February 2025 (1 week ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025
Wednesday 12 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (1 month ago) • Edgar (US Regulatory)

More Madrigal Pharmaceuticals Inc News Articles

Millennium Prime (PK)

Leonteq Securities

Villeroy & Boch

Intesa Sanpaolo

INTESA SANPAOLO

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions